Does REPOTRECTINIB Cause Dizziness? 32 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 32 reports of Dizziness have been filed in association with REPOTRECTINIB (Augtyro). This represents 17.1% of all adverse event reports for REPOTRECTINIB.
32
Reports of Dizziness with REPOTRECTINIB
17.1%
of all REPOTRECTINIB reports
1
Deaths
7
Hospitalizations
How Dangerous Is Dizziness From REPOTRECTINIB?
Of the 32 reports, 1 (3.1%) resulted in death, 7 (21.9%) required hospitalization.
Is Dizziness Listed in the Official Label?
Yes, Dizziness is listed as a known adverse reaction in the official FDA drug label for REPOTRECTINIB.
What Other Side Effects Does REPOTRECTINIB Cause?
Death (21)
Nausea (12)
Adverse event (11)
Neuropathy peripheral (11)
Off label use (10)
Paraesthesia (10)
Balance disorder (9)
Pain (9)
Hospitalisation (8)
Muscular weakness (8)
What Other Drugs Cause Dizziness?
ADALIMUMAB (10,324)
SACUBITRIL\VALSARTAN (8,548)
TREPROSTINIL (7,405)
DULOXETINE (6,983)
LENALIDOMIDE (6,138)
ETANERCEPT (5,928)
METHOTREXATE (5,895)
PREGABALIN (5,878)
TERIPARATIDE (5,539)
AMBRISENTAN (4,561)
Which REPOTRECTINIB Alternatives Have Lower Dizziness Risk?
REPOTRECTINIB vs REQUIP
REPOTRECTINIB vs RESLIZUMAB
REPOTRECTINIB vs RESMETIROM
REPOTRECTINIB vs RESTASIS
REPOTRECTINIB vs RETINOL